CDC weighs risk of BA.2.86 COVID-19 lineage

CDC weighs risk of BA.2.86 COVID-19 lineage

The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and...
Vaccine offers hope against EBV-linked cancers and MS

Vaccine offers hope against EBV-linked cancers and MS

A cutting-edge vaccine candidate developed by QIMR Berghofer has achieved potent and durable immune protection against Epstein–Barr virus (EBV) in preclinical models, a breakthrough that could prevent the type of severe viral infection known to be a leading cause of...
A chance to design better vaccines?

A chance to design better vaccines?

A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19. In this study, the authors...